CSIMarket


Aim Immunotech Inc   (NYSEAMER: AIM)
Other Ticker:  
 

Aim Immunotech Inc

AIM's Fundamental analysis








Aim Immunotech Inc 's sales fell by -23.91 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 780

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Aim Immunotech Inc net loss decreased from $-8 millions, to $-4 millions in III. Quarter 2024,

More on AIM's Growth


Aim Immunotech Inc
realized a net loss in trailing twelve months.

Aim Immunotech Inc realized cash reduction of $ -0.25 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 45.23.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.69.


More on AIM's Valuation
 
 Total Debt (Millions $) 3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 14,615
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.01

Aim Immunotech Inc
realized net loss in trailing twelve months.

Aim Immunotech Inc realized cash outflow of $ -0.25per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 45.23.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.69.

Aim Immunotech Inc Price to Book Ratio is at 2.95 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.02

More on AIM's Valuation

  Market Capitalization (Millions $) 9
  Shares Outstanding (Millions) 58
  Employees 13
  Revenues (TTM) (Millions $) 0
  Net Income (TTM) (Millions $) -24
  Cash Flow (TTM) (Millions $) -14
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) 3
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 14,615
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 0.01

  Market Capitalization (Millions $) 9
  Shares Outstanding (Millions) 58
  Employees 13
  Revenues (TTM) (Millions $) 0
  Net Income (TTM) (Millions $) -24
  Cash Flow (TTM) (Millions $) -14
  Capital Exp. (TTM) (Millions $) -1





  Ratio
   Capital Ratio (MRQ) 0.77
  Total Debt to Equity (MRQ) 0.94
  Tangible Leverage Ratio (MRQ) 26.33
  Asset Turnover Ratio (TTM) 0.01
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com